Thursday, October 29, 2020

Tag: Cannabis

Emerging Growth Cannabis Companies

Can B Corp (CANB) Products, FDA Approved Medical Devices, Subsidiaries and...

In this podcast, Mr. Stanley Teeple discusses the current state of Can B, FDA Products, Brands, and Subsidiaries including their own R&D and production facility.

Can B Corp (CANB) Expands Availability of Insurance Covered Duramed Ultrasound...

Can B Corp (CANB) Expands Availability of Insurance Covered Duramed Ultrasound to the Entire State of Michigan

Cannabics Pharmaceuticals (CNBX) receives “Intention to Grant a European Patent”

Cannabics Pharmaceuticals (CNBX) receives "Intention to Grant a European Patent"

Tonix Pharmaceuticals (TNXP) Could Be a Come-From-Behind Vaccine Shocker

Among small-capitalization companies in the Covid-19 race, Tonix Pharmaceuticals (NASDAQ:TNXP) may be worth consideration with what I would term “dumb money.” Currently, TNXP stock is trading hands for less than a buck, which immediately tells you something about this opportunity’s risk profile.

BioLife Sciences (BLFE) Announces Immediate Commercial Availability of a 10-Minute, Ultra-Rapid,...

Miami, FL – October 26, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for...

Can B’s (CANB) Director and CFO, Stanley Teeple, to Update on...

In the podcast, Mr. Teeple will discuss the current state of Can B Corp, along with its subsidiaries, new product launches, its FDA approved medical device and its strong medical advisory team.

Can B Corp. (OTCQB: CANB) Partners with Dr. Karl Zarse to...

Miami, FL –October 22, 2020, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

Cannabics Pharmaceuticals (CNBX) Prepares to Submit the FDA with a pre-IND...

Cannabics Pharmaceuticals (CNBX) Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS™ RCC-33

Why InflaRx (IFRX) Could Piggyback Off Regeneron’s Sudden Interest

After the initial deadly volley from the novel coronavirus, the broader healthcare industry’s attention shifted from developing treatments to researching and developing...

PAO Group, Inc. (PAOG) FDA Application Process For Respiratory Cannabis Drug...

PAO Group, Inc. (PAOG) FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday